152 related articles for article (PubMed ID: 16756424)
1. The effects of naltrexone on alcohol consumption and affect reactivity to daily interpersonal events among heavy drinkers.
Armeli S; Feinn R; Tennen H; Kranzler HR
Exp Clin Psychopharmacol; 2006 May; 14(2):199-208. PubMed ID: 16756424
[TBL] [Abstract][Full Text] [Related]
2. Targeted naltrexone treatment moderates the relations between mood and drinking behavior among problem drinkers.
Kranzler HR; Armeli S; Feinn R; Tennen H
J Consult Clin Psychol; 2004 Apr; 72(2):317-27. PubMed ID: 15065964
[TBL] [Abstract][Full Text] [Related]
3. Targeted naltrexone for early problem drinkers.
Kranzler HR; Armeli S; Tennen H; Blomqvist O; Oncken C; Petry N; Feinn R
J Clin Psychopharmacol; 2003 Jun; 23(3):294-304. PubMed ID: 12826991
[TBL] [Abstract][Full Text] [Related]
4. A daily process examination of the stress-response dampening effects of alcohol consumption.
Armeli S; Tennen H; Todd M; Carney MA; Mohr C; Affleck G; Hromi A
Psychol Addict Behav; 2003 Dec; 17(4):266-76. PubMed ID: 14640822
[TBL] [Abstract][Full Text] [Related]
5. Targeted versus daily naltrexone: secondary analysis of effects on average daily drinking.
Hernandez-Avila CA; Song C; Kuo L; Tennen H; Armeli S; Kranzler HR
Alcohol Clin Exp Res; 2006 May; 30(5):860-5. PubMed ID: 16634855
[TBL] [Abstract][Full Text] [Related]
6. Positive and negative daily events, perceived stress, and alcohol use: a diary study.
Carney MA; Armeli S; Tennen H; Affleck G; O'Neil TP
J Consult Clin Psychol; 2000 Oct; 68(5):788-98. PubMed ID: 11068965
[TBL] [Abstract][Full Text] [Related]
7. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
[TBL] [Abstract][Full Text] [Related]
8. Effects of naltrexone on alcohol self-administration in heavy drinkers.
Davidson D; Palfai T; Bird C; Swift R
Alcohol Clin Exp Res; 1999 Feb; 23(2):195-203. PubMed ID: 10069545
[TBL] [Abstract][Full Text] [Related]
9. Serum 6-beta-naltrexol levels are related to alcohol responses in heavy drinkers.
McCaul ME; Wand GS; Rohde C; Lee SM
Alcohol Clin Exp Res; 2000 Sep; 24(9):1385-91. PubMed ID: 11003204
[TBL] [Abstract][Full Text] [Related]
10. Naltrexone's effects on reactivity to alcohol cues among alcoholic men.
Rohsenow DJ; Monti PM; Hutchison KE; Swift RM; Colby SM; Kaplan GB
J Abnorm Psychol; 2000 Nov; 109(4):738-42. PubMed ID: 11195999
[TBL] [Abstract][Full Text] [Related]
11. Why would social networks be linked to affect and health practices?
Cohen S; Lemay EP
Health Psychol; 2007 Jul; 26(4):410-7. PubMed ID: 17605560
[TBL] [Abstract][Full Text] [Related]
12. Daily relations among affect, urge, targeted naltrexone, and alcohol use in young adults.
Bold KW; Fucito LM; Corbin WR; DeMartini KS; Leeman RF; Kranzler HR; O'Malley SS
Exp Clin Psychopharmacol; 2016 Oct; 24(5):367-375. PubMed ID: 27690505
[TBL] [Abstract][Full Text] [Related]
13. A daily diary validity test of drinking to cope measures.
Todd M; Armeli S; Tennen H; Carney MA; Affleck G
Psychol Addict Behav; 2003 Dec; 17(4):303-11. PubMed ID: 14640826
[TBL] [Abstract][Full Text] [Related]
14. Naltrexone and brief counseling to reduce heavy drinking in hazardous drinkers.
Davidson D; Saha C; Scifres S; Fyffe J; O'Connor S; Selzer C
Addict Behav; 2004 Aug; 29(6):1253-8. PubMed ID: 15236831
[TBL] [Abstract][Full Text] [Related]
15. Biphasic alcohol response differs in heavy versus light drinkers.
King AC; Houle T; de Wit H; Holdstock L; Schuster A
Alcohol Clin Exp Res; 2002 Jun; 26(6):827-35. PubMed ID: 12068251
[TBL] [Abstract][Full Text] [Related]
16. Patterns of alcohol consumption and alcohol-impaired driving in the United States.
Flowers NT; Naimi TS; Brewer RD; Elder RW; Shults RA; Jiles R
Alcohol Clin Exp Res; 2008 Apr; 32(4):639-44. PubMed ID: 18341648
[TBL] [Abstract][Full Text] [Related]
17. Reduction of alcohol drinking in young adults by naltrexone: a double-blind, placebo-controlled, randomized clinical trial of efficacy and safety.
O'Malley SS; Corbin WR; Leeman RF; DeMartini KS; Fucito LM; Ikomi J; Romano DM; Wu R; Toll BA; Sher KJ; Gueorguieva R; Kranzler HR
J Clin Psychiatry; 2015 Feb; 76(2):e207-13. PubMed ID: 25742208
[TBL] [Abstract][Full Text] [Related]
18. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
[TBL] [Abstract][Full Text] [Related]
19. Does the association between alcohol consumption and depression depend on how they are measured?
Graham K; Massak A; Demers A; Rehm J
Alcohol Clin Exp Res; 2007 Jan; 31(1):78-88. PubMed ID: 17207105
[TBL] [Abstract][Full Text] [Related]
20. Social anxiety and problematic alcohol consumption: the mediating role of drinking motives and situations.
Buckner JD; Eggleston AM; Schmidt NB
Behav Ther; 2006 Dec; 37(4):381-91. PubMed ID: 17071215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
